Dana-Farber’s Breast Oncology Center is leading a phase II study of niraparib with dostarlimab therapy as neoadjuvant treatment for patients with BRCA-mutated #BreastCancer .
For more information call 877-338-7425 or visit: dana-farber.org/clinical-trial…
So incredibly proud of Dr Adam Nelson in the #guerrierolab Brigham and Women’s Department of Surgery Dana-Farber’s Breast Oncology Center for receiving a 3-year CIHR postdoctoral fellowship to study novel ways of treating #brca associated #breastcancer . So grateful to CIHR for this funding!
👇🏼Victory Bell!!
Postpartum #BreastCancer and Survival in Women With Germline #BRCA Pathogenic Variants OHSU Knight Cancer Institute JAMA Network Open
#hereditarycancer #bcsm #genetics #womenshealth #cancerresearch jamanetwork.com/journals/jaman…
Watching my team make a comeback in the Semi-Finals second leg alongside 62k passionate mariners
What a Day!
To the Finals!
Joy Mohun Bagan 💚❤️
Mohun Bagan Super Giant
A new study led by Dr. Zhenzhen Zhang suggests women with #BreastCancer and germline BRCA pathogenic variants had increased all-cause mortality risk if their breast cancer diagnosis occurred within 10 years of giving birth.
Learn more: spr.ly/6015jJi1x
🧵
I recently tested positive for the BRCA-2 gene mutation.
I have realized that few people, including MD/DOs, understand the risk this gene mutation poses to men, so I'd like to shed some light on the subject 💡
#BRCA #Cancer #menshealth #womenshealth #breastcancer
📢Exciting times Previvorship 🥳! We are about to start interviews with people who share information about #brca or #lynchsyndrome on X, Instagram or TikTok! We want to understand how people choose what to share, and how to share it 👇
sites.google.com/sheffield.ac.u…
'Lo que están logrando totocaputo con el pte del BRCA, Bausilli, es extraordinario. Han logrado evitar la hiper, bajar la inflación recomponiendo las reservas, es impresionante' 🗣
José Luis Espert con Roque Galeano en TUCMA TV 📺
Voor geïndividualiseerde #borstkankerscreening wordt ziekveel gelobbyd maar dat vertaalt zich helemaal NIET in betere zorg/inzet voor al die vrouwen met een hóóg risico op borst- en eierstokkanker (60 a 80%) omdat ze een BRCA-mutatie hebben (circa 1 op de 200). Genant is het.
Kreeg je moeder of oma (jong) #borstkanker of #eierstokkanker ? Is er erfelijkheidsonderzoek gedaan? Eén op de 200 mensen heeft een #BRCA -mutatie. En die kun je overdragen aan je kinderen. Even bespreken met de huisarts?
Ashok Venkitaraman & colleagues address a fundamental question that has plagued the BRCA field for years - why do individuals with monoallelic germline mutations of BRCA2 still get cancers like #PancreaticCancer , sans a classic “second hit”. Fantastic study tying aberrant
